← Open Payments lookup

EDWARD ZAWADZKI: Open Payments

NPI 1346467305 · JUPITER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$506 in 26 payments from 13 companies in 2025. Trend: 2023 $155 · 2024 $554 · 2025 $506

Food & beverage: $506
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.4$88
Otsuka America Pharmaceutical, Inc.4$81
Takeda Pharmaceuticals U.S.A., Inc.3$50
ABBVIE INC.2$49
Vanda Pharmaceuticals Inc.2$39
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$39
Teva Pharmaceuticals USA, Inc.2$38
Indivior Inc.2$31
Neuronetics, Inc.1$22
Braeburn Inc.1$21

Products named: REXULTI, INGREZZA, TRINTELLIX, VRAYLAR, FANAPT, CAPLYTA, AUSTEDO XR, SUBLOCADE.

Industry payments across FL — which companies pay providers there.